Targeting the RBD of Omicron Variant (B.1.1.529) with Medicinal Phytocompounds to Abrogate the Binding of Spike Glycoprotein with the hACE2 Using Computational Molecular Search and Simulation Approach
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus continues to inflict chaos globally. The emergence of a novel Omicron variant (B.1.1.529) in South Africa harbors 30 mutations in the spike protein. The variant is distinguished from other variants of concern (VOCs) with an incre...
Main Author: | Abdulrahim R. Hakami |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/11/2/258 |
Similar Items
-
Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador
by: Andrés Carrazco-Montalvo, et al.
Published: (2022-05-01) -
Vaccination and Transmission Risk during the Outbreak of B.1.1.529 (Omicron)
by: Barbara Grüne, et al.
Published: (2022-06-01) -
A study on the effect of natural products against the transmission of B.1.1.529 Omicron
by: Samar Sami Alkafaas, et al.
Published: (2023-08-01) -
The updated strategy to overcome new challenge: Omicron variant (B.1.1.529) pandemic
by: HyokJu Ri, et al.
Published: (2022-03-01) -
First detection of SARS-CoV-2 variant B.1.1.529 (Omicron) in Ecuador
by: A. Carrazco-Montalvo, et al.
Published: (2022-01-01)